Summary
Interference of antiviral agent adefovir, i.e. 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with microsomal drug metabolizing system was investigated in rats. The content of total liver cytochrome P450 (CYP) was lowered while that of its denaturated form, P420, was elevated in animals intraperitoneally treated with PMEA (25 mg/kg). Similar effect was observed after treatment with a prodrug of adevofir, adefovir dipivoxil (bisPOM-PMEA). The CYP2E1-dependent formation of 4-nitrocatechol from p-nitrophenol was diminished, though the specific activity of p-nitrophenol hydroxylase remained unchanged. PMEA had no influence on expression of CYP2E1 protein and mRNA and mRNAs of other P450 isoenzymes (1A1, 1A2, 2C11, 3A1, 3A2, and 4A1). It may be concluded that repeated systemic administration of higher doses of PMEA results in a partial degradation of rat CYP protein to inactive P420.
Article PDF
Similar content being viewed by others
References
Holý A. (2003). Phosphonomethoxyalkyl analogs of nucleotides. Curr. Pharmaceut. Design 9:2567–2592
Hesse L.M., von Moltke L.L., Shader R.I., Greenblatt D.J. (2001). Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion. Drug Metab. Disp. 29:100–102
von Moltke L.L., Greenblatt D.J., Granda B.W., Giancarlo G.M., Duan S.X., Daily J.P., Harmatz J.S., Shader R.I. (2001). Inhibition of human cytochrome P450 isoforms by nonucleotide reverse transcriptase inhibitors. J. Clin. Pharmacol. 41:85–91
Shaw J.P., Louie H.S., Krishnamurthy V.V., Arimilli M.N., Jones R.J., Bidgood A.M., Lee W.A., Cundy K.C. (1997). Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats. Drug Metab. Disp. 25:362–366
Omura T., Sato R. (1967) Isolation of cytochromes P450 and P420. Meth. Enzymol. 10:556–561
Chang T.K.H., Crespi C.L., Waxman D.J. (1998). Spectrophotometric analysis of human CYP2E1-catalyzed p-nitrophenol hydroxylation. In: Phillips I.R., Shephard E.A. (eds), Methods in Molecular Biology, Vol. 107: Cytochrome P450 Protocols. Humana Press Inc., Totowa, pp. 147–152
Morris D.L., Davila J.C. (1996). Analysis of rat cytochrome P450 isoenzyme expression using semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). Biochem. Pharmacol. 52:781–792
Anzenbacher P., Anzenbacherová E. (2001). Cytochromes P450 and metabolism of xenobiotics. Cell Mol. Life Sci. 58:737–747
Guengerich F.P. (1995). Human cytochromes P450. In: Ortiz de Montellano P.R. (eds), Cytochromes P450. Plenum Press, New York, pp. 106–176
Guengerich F.P. (1997). Comparisons of catalytic selectivity of cytochrome P450 enzymes from different species. Chem. Biol. Interact. 106:161–182
Court M.H., von Moltke L.L., Shader R.I., Grenblatt D.J. (1997). Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species. Biopharm. Drug Dispos. 18:213–226
Oesch-Bartlomowicz B., Oesch F. (2003). Cytochrome P450 phosphorylation as a functional switch. Arch. Biochem. Biophys. 409:228–234
Zídek Z., Holý A., Franková D., Otová B. (1995). Supression of adjuvant arthritis by some acyclic nucleotide analogs. Eur. J. Pharmacol. 286:307–310
Hadziyannis S.J., Papatheodoridis G.V. (2004). Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection. Expert Rev. Anti-infect. Ther. 2:475–483
Acknowledgements
As a part of research project AV0Z50390512, the study was supported from the Grant Agency of the Czech Republic (project no. 305/04/0127).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zídek, Z., Anzenbacher, P., Anzenbacherová, E. et al. In vivo effects of antiviral acyclic nucleoside phosphonate 9-[2-(phosphonomethoxy)ethyl]adenine (adefovir) on cytochrome P450 system of rat liver microsomes. J Biomed Sci 13, 295–301 (2006). https://doi.org/10.1007/s11373-005-9067-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11373-005-9067-1